Private Market View

DNA Script

Biotechnology · Paris, France · Founded 2014 · Privately Held (backing)

Last price · $/share
Implied valuation
$659.7M
Total raised
$298.7M
Last round
Later Stage VC (Series C)
Jan 2022
What is DNA Script worth?
$659.7Mlast known valuation

DNA Script last raised $191.7M in its Later Stage VC (Series C) (Jan 2022).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 34 names
  • ·Watchlist + deal alerts for DNA Script
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Jan 2022Later Stage VC (Series C)$191.7M

How DNA Script's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For DNA Script, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is DNA Script worth?
DNA Script's last known valuation is $659.7M.
How much has DNA Script raised?
DNA Script has raised $298.7M in total funding across 1 recorded rounds.
When did DNA Script last raise?
DNA Script last raised in Jan 2022 (Later Stage VC (Series C)), raising $191.7M.